1. Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors
   Ibrahim H. Kankia et al, 2021, Exploration of Targeted Anti-tumor Therapy CrossRef
2. Unique Pattern of Component Gene Disruption in the NRF2 Inhibitor KEAP1/CUL3/RBX1 E3-Ubiquitin Ligase Complex in Serous Ovarian Cancer
   Victor D. Martinez et al, 2014, BioMed Research International CrossRef